Copyright Reports & Markets. All rights reserved.

Global Axillary Hyperhidrosis Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Axillary Hyperhidrosis Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Product
      • 1.4.2 Botulinum ToxinA
      • 1.4.3 Glycopyrrolate
      • 1.4.4 Glycopyrronium Tosylate
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Home Care
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Axillary Hyperhidrosis Drug Market Size
      • 2.1.1 Global Axillary Hyperhidrosis Drug Revenue 2014-2025
      • 2.1.2 Global Axillary Hyperhidrosis Drug Sales 2014-2025
    • 2.2 Axillary Hyperhidrosis Drug Growth Rate by Regions
      • 2.2.1 Global Axillary Hyperhidrosis Drug Sales by Regions
      • 2.2.2 Global Axillary Hyperhidrosis Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Axillary Hyperhidrosis Drug Sales by Manufacturers
      • 3.1.1 Axillary Hyperhidrosis Drug Sales by Manufacturers
      • 3.1.2 Axillary Hyperhidrosis Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Axillary Hyperhidrosis Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Axillary Hyperhidrosis Drug Revenue by Manufacturers
      • 3.2.1 Axillary Hyperhidrosis Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Axillary Hyperhidrosis Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Axillary Hyperhidrosis Drug Price by Manufacturers
    • 3.4 Axillary Hyperhidrosis Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Axillary Hyperhidrosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Axillary Hyperhidrosis Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Axillary Hyperhidrosis Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Axillary Hyperhidrosis Drug Sales by Product
    • 4.2 Global Axillary Hyperhidrosis Drug Revenue by Product
    • 4.3 Axillary Hyperhidrosis Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Axillary Hyperhidrosis Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Axillary Hyperhidrosis Drug by Countries
      • 6.1.1 North America Axillary Hyperhidrosis Drug Sales by Countries
      • 6.1.2 North America Axillary Hyperhidrosis Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Axillary Hyperhidrosis Drug by Product
    • 6.3 North America Axillary Hyperhidrosis Drug by End User

    7 Europe

    • 7.1 Europe Axillary Hyperhidrosis Drug by Countries
      • 7.1.1 Europe Axillary Hyperhidrosis Drug Sales by Countries
      • 7.1.2 Europe Axillary Hyperhidrosis Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Axillary Hyperhidrosis Drug by Product
    • 7.3 Europe Axillary Hyperhidrosis Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Axillary Hyperhidrosis Drug by Countries
      • 8.1.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Countries
      • 8.1.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Axillary Hyperhidrosis Drug by Product
    • 8.3 Asia Pacific Axillary Hyperhidrosis Drug by End User

    9 Central & South America

    • 9.1 Central & South America Axillary Hyperhidrosis Drug by Countries
      • 9.1.1 Central & South America Axillary Hyperhidrosis Drug Sales by Countries
      • 9.1.2 Central & South America Axillary Hyperhidrosis Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Axillary Hyperhidrosis Drug by Product
    • 9.3 Central & South America Axillary Hyperhidrosis Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Axillary Hyperhidrosis Drug by Countries
      • 10.1.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Countries
      • 10.1.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Axillary Hyperhidrosis Drug by Product
    • 10.3 Middle East and Africa Axillary Hyperhidrosis Drug by End User

    11 Company Profiles

    • 11.1 Allergan Plc
      • 11.1.1 Allergan Plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Allergan Plc Axillary Hyperhidrosis Drug Products Offered
      • 11.1.5 Allergan Plc Recent Development
    • 11.2 Brickell Biotech Inc
      • 11.2.1 Brickell Biotech Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Products Offered
      • 11.2.5 Brickell Biotech Inc Recent Development
    • 11.3 Dermira Inc
      • 11.3.1 Dermira Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Dermira Inc Axillary Hyperhidrosis Drug Products Offered
      • 11.3.5 Dermira Inc Recent Development
    • 11.4 Dr. August Wolff GmbH & Co KG Arzneimittle
      • 11.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Products Offered
      • 11.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Development
    • 11.5 GlaxoSmithKline Plc
      • 11.5.1 GlaxoSmithKline Plc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Products Offered
      • 11.5.5 GlaxoSmithKline Plc Recent Development
    • 11.6 TheraVida Inc
      • 11.6.1 TheraVida Inc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 TheraVida Inc Axillary Hyperhidrosis Drug Products Offered
      • 11.6.5 TheraVida Inc Recent Development

    12 Future Forecast

    • 12.1 Axillary Hyperhidrosis Drug Market Forecast by Regions
      • 12.1.1 Global Axillary Hyperhidrosis Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Axillary Hyperhidrosis Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Axillary Hyperhidrosis Drug Market Forecast by Product
      • 12.2.1 Global Axillary Hyperhidrosis Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Axillary Hyperhidrosis Drug Revenue Forecast by Product 2019-2025
    • 12.3 Axillary Hyperhidrosis Drug Market Forecast by End User
    • 12.4 North America Axillary Hyperhidrosis Drug Forecast
    • 12.5 Europe Axillary Hyperhidrosis Drug Forecast
    • 12.6 Asia Pacific Axillary Hyperhidrosis Drug Forecast
    • 12.7 Central & South America Axillary Hyperhidrosis Drug Forecast
    • 12.8 Middle East and Africa Axillary Hyperhidrosis Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Axillary Hyperhidrosis Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Axillary Hyperhidrosis Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Axillary Hyperhidrosis Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Axillary Hyperhidrosis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Axillary Hyperhidrosis Drug in these regions.
      This research report categorizes the global Axillary Hyperhidrosis Drug market by top players/brands, region, type and end user. This report also studies the global Axillary Hyperhidrosis Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Allergan Plc
      Brickell Biotech Inc
      Dermira Inc
      Dr. August Wolff GmbH & Co KG Arzneimittle
      GlaxoSmithKline Plc
      TheraVida Inc

      Market size by Product
      Botulinum ToxinA
      Glycopyrrolate
      Glycopyrronium Tosylate
      Others
      Market size by End User
      Clinic
      Hospital
      Home Care

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Axillary Hyperhidrosis Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Axillary Hyperhidrosis Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Axillary Hyperhidrosis Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Axillary Hyperhidrosis Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Axillary Hyperhidrosis Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Axillary Hyperhidrosis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now